Recruiting

Observational Study

Sponsor:

University of Rochester

Code:

NCT07505342

Conditions

Myotonic Dystrophy Type 1 (DM1)

DM1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The goal of this observational study, conducted in participants' homes and requiring no travel to a study site, is to better understand disease variability in people with myotonic dystrophy type 1 (DM1) and to identify effective ways to measure symptoms.

Myotonic dystrophy is one of the most variable diseases. Some people develop symptoms when they are young, others when they are much older. In the same family, some people may have mild problems, while others are strongly affected. The goal of this study is to find out more about what is causing these differences. To accomplish this, investigators will study the effects of DM1 on skeletal and smooth muscles, the heart, and the nervous system. Then, investigators will evaluate genetic differences with a blood sample.

  • Participants will receive a toolkit in the mail which includes all necessary equipment to participate in the study, including an iPad with video conferencing software.
  • Then the study team will connect with participants via videoconferencing for medical interview about DM1 symptoms and functional assessments
  • Participants will have their blood drawn in a lab in their community or using a home draw device, and ship it to us for research genetic analysis
  • Participants can chose to have their research genetic test result returned to them

Conditions

Myotonic Dystrophy Type 1 (DM1)

DM1

Study ID

NCT07505342

Start date

May 10, 2022

Status verified date

Mar, 2026

Completion date

Jan 1, 2030

Anticipated

Primary completion date

Jan 1, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age 18-88 years
  • Clinical diagnosis of DM1
  • English speaking
  • Able to provide informed consent
  • Available wifi

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Remote assessment of grip strength [ Time Frame: 12 months ]
  • Remote assessment of cognitive function [ Time Frame: 12 months ]
  • Remote assessment of activity [ Time Frame: 12 months ]
  • Genetic test [ Time Frame: at baseline ]
  • Timed Up and Go [ Time Frame: 12 months ]

Central Contacts and Locations

Central contacts

Locations

University of Rochester

Recruiting

Rochester, New York, United States, 14642

Contacts

Principal Investigator:

Johanna Hamel, MD

More Information

Sponsor

University of Rochester

Last update posted

Apr 1, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Rochester on 2026-04-01.